NRBO - NeuroBo Pharmaceuticals, Inc.

QQQ $ 430.17 $ -2.06 (-0.48 %)

DIA $ 380.88 $ -3.52 (-0.92 %)

SPY $ 507.81 $ 5.55 (1.11 %)

TLT $ 87.78 $ -0.61 (-0.69 %)

GLD $ 215.92 $ 1.28 (0.6 %)

Previous Close

$ 3.06

Open

$ 3.12

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 3.09 - $ 3.12

52 Week Range

$ 2.89 - $ 6.75

Volume

39,360

Average Volume

Market Cap

15.72M

Beta (5Y Monthly)

$ 1.52

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-28-2024	12-31-2023	10-K
2	11-13-2023	09-30-2023	10-Q
3	08-09-2023	06-30-2023	10-Q
4	05-12-2023	03-31-2023	10-Q
5	03-30-2023	12-31-2022	10-K
6	11-14-2022	09-30-2022	10-Q
7	08-12-2022	06-30-2022	10-Q
8	05-13-2022	03-31-2022	10-Q
9	03-31-2022	12-31-2021	10-K
10	11-15-2021	09-30-2021	10-Q
11	08-16-2021	06-30-2021	10-Q
12	05-17-2021	03-31-2021	10-Q
13	04-15-2021	12-31-2020	10-K
14	11-13-2020	09-30-2020	10-Q
15	08-11-2020	06-30-2020	10-Q
16	05-20-2020	03-31-2020	10-Q
17	03-30-2020	12-31-2019	10-K
18	11-08-2019	09-30-2019	10-Q
19	08-09-2019	06-30-2019	10-Q
20	05-09-2019	03-31-2019	10-Q
21	03-18-2019	12-31-2018	10-K
22	11-08-2018	09-30-2018	10-Q
23	08-14-2018	06-30-2018	10-Q
24	05-08-2018	03-31-2018	10-Q
25	03-20-2018	12-31-2017	10-K
26	11-13-2017	09-30-2017	10-Q
27	08-14-2017	06-30-2017	10-Q
28	05-10-2017	03-31-2017	10-Q
29	03-21-2017	12-31-2016	10-K
30	11-02-2016	09-30-2016	10-Q
31	09-14-2016	06-30-2016	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

NeuroBo Pharmaceuticals Doses First Patien...
04/17/2024 12:06:54

NeuroBo Pharmaceuticals Files For Mixed Sh...
04/12/2024 20:13:57

https://www.sec.gov/Archives/edgar/data/1638287/000155837024005018/tmb-20240412xs3.htm

NeuroBo Pharmaceuticals Completes Enrollme...
04/01/2024 12:10:35

NeuroBo Pharmaceuticals Receives Safety Re...
03/13/2024 12:04:18

NeuroBo Pharmaceuticals Appoints Marshall ...
03/04/2024 12:39:00

On March 1, 2024, the Board of Directors (the “Board”) of NeuroBo Pharmaceuticals, Inc. (the “Company”) appointed Mr. Marshall ...

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
02/29/2024 13:07:01

NeuroBo Pharmaceuticals Receives First Sit...
02/29/2024 13:05:58

dow-jumps-250-points-honeywell-issues-weak-forecast

Dow Jumps 250 Points; Honeywell Issues Wea...
02/01/2024 19:20:04

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday. The Dow t...

Why C.H. Robinson Shares Are Trading Lower...
02/01/2024 18:17:44

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
02/01/2024 17:31:27

Crude Oil Gains 1%; ISM Manufacturing PMI ...
02/01/2024 17:04:43

U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday. The Dow traded up 0.23...

why-obesity-drug-maker-neurobo-stock-is-trading-higher

Why Obesity-Drug Maker NeuroBo Stock Is Tr...
02/01/2024 15:08:44

NeuroBo announced that the FDA has cleared its IND application for DA-1726, a novel, dual oxyntomodulin (OXM) analog agonist th...

nasdaq-surges-100-points-us-jobless-claims-increase-to-224000

Nasdaq Surges 100 Points; US Jobless Claim...
02/01/2024 14:45:08

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Thursday. Following the mark...

Market-Moving News for February 1st
02/01/2024 13:35:59

NRBO: 103% | NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment o...

NeuroBo Pharmaceuticals Announces FDA Clea...
02/01/2024 13:02:17

NeuroBo Reports Pre-Clinical Safety Data O...
01/18/2024 13:04:02

The pre-clinical results demonstrated that once daily oral administration in rats, of sitagliptin alone (180 mg/kg/day), DA-124...

NeuroBo Pharmaceuticals Regains Compliance...
01/09/2024 13:41:45

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic dis...

What's Going On With Clinical-Stage Biotec...
12/29/2023 12:58:58

NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares are trading lower in Friday's premarket session after ending Thursday&#...

NeuroBo Pharmaceuticals Submits IND Applic...
12/28/2023 13:46:52

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic dis...

NeuroBo Pharmaceuticals Announces 1-For-8 ...
12/19/2023 13:45:01

Commencement of Trading on Split-Adjusted Basis on December 21, 2023BOSTON, Dec. 19, 2023 /PRNewswire/ -- NeuroBo Pharmaceutica...